Lahti Adrienne C, Holcomb Henry H, Weiler Martin A, Medoff Deborah R, Frey Kristin N, Hardin Michael, Tamminga Carol A
Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228, USA.
Neuropsychopharmacology. 2004 Jan;29(1):171-8. doi: 10.1038/sj.npp.1300312.
Our previous work has identified that unmedicated volunteers with schizophrenia have regional cerebral blood flow (rCBF) activation patterns inappropriately related to the cognitive demand of a task in anterior cingulate cortex (ACC). Using positron emission tomography (PET) with (15)O water, we compared task-induced rCBF patterns induced by haloperidol or clozapine in individuals with schizophrenia. We hypothesized that clozapine, given its superior clinical action, would tend to normalize the abnormal task-activated response in ACC more than haloperidol. Schizophrenia volunteers (SVs) (n=6) and normal volunteers (NVs) (n=12) were trained to perform a tone discrimination task with 70-80% accuracy. They were then scanned during three task conditions: (1). Rest, (2). sensory motor control (SMC) task, and (3). decision task (DEC). SVs were initially scanned after withdrawal of all psychotropic medication and again after treatment with therapeutic doses of haloperidol (n=5) and/or clozapine (n=5). rCBF values, sampled in the grown maxima of the task-activated ACC cluster, were analyzed between groups and task conditions. Task performance was similar across the unmedicated, haloperidol- and clozapine-medicated SV groups. There was a reduction in accuracy in the haloperidol SV group compared to the NVs. Group and task conditions affected rCBF in the ACC. Clozapine, but not haloperidol, reversed the abnormal ACC rCBF pattern in unmedicated SV to normal. The clozapine-treated SV group showed a rCBF pattern similar to the NV group in that ACC activation was not observed during the control task but occurred during the decision condition. The pattern seen in the haloperidol-treated SV group was similar to the unmedicated SV group in that ACC activation was seen during the control task and no further activation was seen during the DEC. We report that clozapine, but not haloperidol, normalizes anterior cingulate rCBF patterns in schizophrenia during a cognitive task. Based on these preliminary data, we propose that this pattern may account for the superior therapeutic effect of clozapine and represents a surrogate marker of this action.
我们之前的研究发现,未服用药物的精神分裂症志愿者在前扣带回皮质(ACC)中,其局部脑血流量(rCBF)激活模式与任务的认知需求存在不适当的关联。我们使用(15)O水正电子发射断层扫描(PET),比较了精神分裂症患者中,氟哌啶醇或氯氮平诱导的任务诱发rCBF模式。我们假设,鉴于氯氮平具有更优的临床疗效,它比氟哌啶醇更倾向于使ACC中异常的任务激活反应恢复正常。精神分裂症志愿者(SVs)(n = 6)和正常志愿者(NVs)(n = 12)接受训练以执行准确率为70 - 80%的音调辨别任务。然后在三种任务条件下对他们进行扫描:(1)休息,(2)感觉运动控制(SMC)任务,以及(3)决策任务(DEC)。SVs最初在停用所有精神药物后进行扫描,之后再用治疗剂量的氟哌啶醇(n = 5)和/或氯氮平(n = 5)治疗后再次扫描。在任务激活的ACC簇的峰值处采集的rCBF值,在不同组和任务条件之间进行分析。未服药、服用氟哌啶醇和服用氯氮平的SV组的任务表现相似。与NVs相比,氟哌啶醇SV组的准确率有所降低。组和任务条件影响了ACC中的rCBF。氯氮平而非氟哌啶醇,将未服药SV中ACC的异常rCBF模式恢复到正常。氯氮平治疗的SV组显示出与NV组相似的rCBF模式,即在控制任务期间未观察到ACC激活,但在决策条件下出现激活。氟哌啶醇治疗的SV组中看到的模式与未服药的SV组相似,即在控制任务期间观察到ACC激活,而在DEC期间未观察到进一步激活。我们报告,在认知任务期间,氯氮平而非氟哌啶醇可使精神分裂症患者的前扣带回rCBF模式恢复正常。基于这些初步数据,我们提出这种模式可能解释了氯氮平的优越治疗效果,并代表了这种作用的替代标志物。